“100 B a year with cancer treatment , possibly s
Post# of 148168
(Total Views: 593)
Posted On: 02/24/2020 10:18:42 PM
“100 B a year with cancer treatment , possibly starting this year “ I agree with this.”
I believe in leronlimab and look forward to making a nice profit on my investment, but the above statement is out of the question. It will take months to fill the basket trial (screening of patients, etc) and even longer than that to get the data together, etc. It’s nearly March and we only have 5 patients in the mTNBC/mBC trials, which demonstrates how the process takes time. And that process is important so CYDY enrolls patients that are most likely to respond to the mechanism of action of leronlimab.
The only way CYDY speeds up the enrollment process is to throw cash at it, which is difficult with the BLA submission pending. Maybe a non-dilutive financing deal will help push the trial along quicker?
I believe in leronlimab and look forward to making a nice profit on my investment, but the above statement is out of the question. It will take months to fill the basket trial (screening of patients, etc) and even longer than that to get the data together, etc. It’s nearly March and we only have 5 patients in the mTNBC/mBC trials, which demonstrates how the process takes time. And that process is important so CYDY enrolls patients that are most likely to respond to the mechanism of action of leronlimab.
The only way CYDY speeds up the enrollment process is to throw cash at it, which is difficult with the BLA submission pending. Maybe a non-dilutive financing deal will help push the trial along quicker?
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼